German Pharmaceuticals & Biotech Most Popular Stocks

Merck KGaA

Market Cap: €47.9b

Operates as a science and technology company in Germany and internationally.

Bayer

Market Cap: €35.8b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

SCHOTT Pharma KGaA

Market Cap: €2.1b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Hamlet BioPharma

Market Cap: €1.1b

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Evotec

Market Cap: €957.9m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Gerresheimer

Market Cap: €655.9m

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

PEPTONIC medical

Market Cap: €560.2m

A medical technology company, develops and sells intimate self-care products for women.

Formycon

Market Cap: €348.7m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Dextech Medical

Market Cap: €199.6m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer in Sweden.

Heidelberg Pharma

Market Cap: €143.6m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

Darwin

Market Cap: €96.0m

Operates in the healthcare industry.

MPH Health Care

Market Cap: €86.5m

An investment company, engages in the healthcare business in Germany.

2invest

Market Cap: €62.9m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally.

Cantourage Group

Market Cap: €59.0m

Operates as a medical cannabis company in Europe and internationally.

Genetic Analysis

Market Cap: €47.0m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Biomark Diagnostics

Market Cap: €38.3m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

PExA

Market Cap: €29.5m

Develops and commercializes diagnostic products for various respiratory diseases.

Vidac Pharma Holding

Market Cap: €29.4m

An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.

Biofrontera

Market Cap: €15.9m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

SynBiotic

Market Cap: €14.0m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

Respiratorius

Market Cap: €10.3m

A research company, develops pharmaceuticals for the treatment of cancer.

TFF Pharmaceuticals

Market Cap: €9.7m

A clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia.

Vitruvia Medical

Market Cap: €3.5m

A technology company, operates in the healthcare sector.

Cannovum Cannabis

Market Cap: €1.1m

Engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin.

Epigenomics

Market Cap: €841.9k

Does not have significant operations.

Paion

Market Cap: €470.8k

A specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide.

co.don

Market Cap: €347.4k

Does not have significant operations.

bioXXmed

Market Cap: €318.1k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

bioXXmed

Market Cap: €329.8k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.